Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 6:10 pm Unchanged |
2024-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
Venrock Healthcare Capital Partners III L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
2025-02-13 3:25 pm Purchase |
2024-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 2,373,404 11.400% |
167,058![]() (+7.57%) |
Filing History |
2024-12-17 5:11 pm Purchase |
2024-12-17 | 13G | Adverum Biotechnologies, Inc. ADVM |
Rush Ryan Bradford | 1,050,000 5.100% |
1,050,000![]() (New Position) |
Filing History |
2024-11-14 6:57 pm Purchase |
2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
Vivo Opportunity Fund Holdings, L.P. | 218,895 1.100% |
218,895![]() (New Position) |
Filing History |
2024-11-14 6:40 pm Purchase |
2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
Logos Global Management LP | 416,666 2.000% |
416,666![]() (New Position) |
Filing History |
2024-11-14 4:05 pm Unchanged |
2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
Commodore Capital LP | 0 0.000% |
0 (Unchanged) |
Filing History |
2024-11-12 09:50 am Purchase |
2024-11-08 | 13G | Adverum Biotechnologies, Inc. ADVM |
FMR CORP | 234,718 1.128% |
234,718![]() (New Position) |
Filing History |
2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
BLACKROCK INC BLK |
1,490,709 7.200% |
0 (Unchanged) |
Filing History |
2024-11-06 5:49 pm Purchase |
2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
MORGAN STANLEY MS |
78,862 0.400% |
78,862![]() (New Position) |
Filing History |
2024-10-31 12:41 pm Purchase |
2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
FRANKLIN RESOURCES INC BEN |
1,760,056 8.500% |
1,760,056![]() (New Position) |
Filing History |
2024-10-30 9:34 pm Purchase |
2024-10-29 | 13G | Adverum Biotechnologies, Inc. ADVM |
Stern Augustus | 1,116,628 5.370% |
1,116,628![]() (New Position) |
Filing History |
2024-10-23 1:34 pm Purchase |
2024-10-22 | 13G | Adverum Biotechnologies, Inc. ADVM |
Principia Wealth Advisory LLC | 1,055,103 5.070% |
1,055,103![]() (New Position) |
Filing History |
2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
BLACKROCK INC BLK |
1,490,709 7.200% |
1,490,709![]() (New Position) |
Filing History |
2024-07-22 4:24 pm Purchase |
2024-07-17 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 2,206,346 10.600% |
1,065,346![]() (+93.37%) |
Filing History |
2024-05-14 5:06 pm Sale |
2024-03-21 | 13D | Adverum Biotechnologies, Inc. ADVM |
Versant Ventures IV LLC | 500,387 2.400% |
-2![]() (-0.00%) |
Filing History |
2024-04-29 4:10 pm Purchase |
2024-04-18 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 1,141,000 5.500% |
655,575![]() (+135.05%) |
Filing History |
2024-02-22 3:47 pm Purchase |
2024-02-06 | 13G | Adverum Biotechnologies, Inc. ADVM |
Logos Global Management LP | 1,500,000 7.200% |
1,500,000![]() (New Position) |
Filing History |
2024-02-15 4:17 pm Purchase |
2024-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM |
TCG Crossover GP II, LLC | 2,076,357 9.900% |
2,076,357![]() (New Position) |
Filing History |
2024-02-14 8:26 pm Purchase |
2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
Venrock Healthcare Capital Partners III L.P. | 1,556,421 7.500% |
966,472![]() (+163.82%) |
Filing History |
2024-02-14 4:30 pm Purchase |
2024-02-07 | 13G | Adverum Biotechnologies, Inc. ADVM |
Vivo Opportunity Fund Holdings, L.P. | 1,500,000 7.200% |
1,500,000![]() (New Position) |
Filing History |